Delivery Order SPE2DB25D3306-SPE2DB25FUCVW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $2,119.10. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- The Defense Logistics Agency awarded a delivery order valued at $4,402.77 to AmerisourceBergen Drug Corp for the supply of Methotrexate 2.5 mg tablets in unit dose packaging of 20s. This firm fixed price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 units of Methotrexate 2.5 mg tablets. The $2,294.28 order has a completion date of December 22, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has previously received multiple awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related...
- This federal contract award is a delivery order valued at $6,361.41 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of methotrexate 2.5 mg tablets and has a completion date of November 5, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency Troop Support Medical awarded a $132,100 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be delivered to a facility in Conshohocken, Pennsylvania by September 19, 2023. Amerisourcebergen will serve as the prime contractor to supply the requested prescription drugs to the Defense...
- The Defense Logistics Agency awarded a $74,940 delivery order to Amerisourcebergen Drug Corporation for the supply of 20 boxes of 2.5 mg methotrexate tablets. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products from its location in Conshohocken, Pennsylvania to an unspecified customer of the DLA. Performance is required between July 25-26, 2023. The firm fixed price contract has no set-aside designation. As the DLA's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methotrexate 2.5 mg tablets. The contract, valued at $2,294.28, is a firm-fixed-price delivery order with an ultimate completion date of August 9, 2024. Amerisourcebergen, through its corporate office division, will provide these pharmaceutical products to support federal healthcare programs and military treatment facilities. This...
- The Defense Logistics Agency Troop Support Medical awarded a $29,840 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide the pharmaceutical products from its facility in Conshohocken, Pennsylvania, with delivery required between July 14-17, 2023. The pricing is firm fixed price. No subcontractors or set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Methotrexate 2.5 mg tablets. The award, valued at $13,033.23, is a firm fixed price delivery order contract with an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products to support military treatment programs and facilities. This award is...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,678,591 units of Methotrexate 2.5 mg tablets in 100-count bottles. The contract has a ceiling value of $21,076.61 and runs through March 25, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCVWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $15,845.94. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply framework with the federal government. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Methotrexate, a critical medication used in treating various conditions including cancer and autoimmune disorders, represents the type of essential pharmaceutical commodity that DLA procures to support Department of Defense medical supply chain requirements and healthcare systems serving military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 9/2/25 |